PulseAugur
EN
LIVE 21:46:04
中文(ZH) 工业和信息化部:今年上半年我国医药工业创新能力显著增强

China's Pharma Innovation Surges: 31 Domestic Drugs Approved, $100B+ in Licensing Deals

China's pharmaceutical industry has seen a significant boost in innovation during the first half of the year, with 38 new drugs approved, 31 of which were domestically developed. This surge includes several "first-in-the-world" drug discoveries and a record-breaking year for technology licensing, with over $100 billion in transaction value. These achievements indicate a systemic improvement in the quality and innovation of China's pharmaceutical sector. AI

RANK_REASON Governmental announcement of industry performance and achievements. [lever_c_demoted from significant: ic=1 ai=0.0]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

China's Pharma Innovation Surges: 31 Domestic Drugs Approved, $100B+ in Licensing Deals

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Ministry of Industry and Information Technology: China's pharmaceutical industry's innovation capabilities have been significantly enhanced in the first half of this year

    今天(20日)上午十点,国务院新闻办公室举办新闻发布会,工业和信息化部相关负责人介绍今年上半年工业和信息化发展情况。运行监测协调局局长陶青介绍,今年上半年我国医药工业创新能力显著增强,在首创新药、高端医疗器械等方面取得丰硕成果。今年上半年,38款创新药获批上市,其中国产创新药31款,占比超过80%。我国创新药高质量成果不断涌现,一批“全球首个”创新成果集中获批上市。创新药对外技术授权再创新高,今年上半年交易总额超过1000亿美元,充分展现我国医药产业创新质量实现系统性跃升。(央视新闻)